Efficacy and Safety of 675-nm Laser for Dorsal Hand Rejuvenation
- Conditions
- Wrinkle
- Interventions
- Device: Redtouch
- Registration Number
- NCT06486727
- Lead Sponsor
- Mahidol University
- Brief Summary
This study aimed to evaluate efficacy and safety of 675-nm laser for dorsal hand rejuvenation in Thai patients. Twenty-six subjects aged 50 to 65 years diagnosed with wrinkle and solar lentigines on both dorsums of hands were included and treated with RedTouch for 3 times every 4 weeks. Then, they were follow up at 3 and 6 months after the final treatment. The measurement of 5-point Global Aesthetic Improvement Scale scores by physicians and subjects were conducted. Moreover, pigmentation level, wrinkle and texture were also recored using Antera. Elasticity was measured using Cutometer.
- Detailed Description
RedTouch parameter included Moveo, power 5 W, Energy/DOT 500 mJ/DOT, then Standard, power 4 W, spacing 2000 μm, 1 pass per side.
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 26
- Subjects diagnosed with wrinkles and solar lentigines on both dorsum of hands
- Pregnant or lactation
- Sugjects with a history of allergy to near-infrared wavelength or photosensitizing agents
- Subjects who have been treated with any kind of energy-based device on both dorsum of hands 6 months prior to the inclusion
- Subjects who have been injected with filler, or platelet-rich plasma on both dorsum of hands on their faces 6 months prior to the inclusion
- Active skin infections
- History of hypertrophic scars or keloids
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description 675-nm laser (RedTouch) Redtouch Paramete: Moveo, power 5 W, Energy/DOT 500 mJ/DOT then Standard, power 4 W, spacing 2000 μm, 1 pass per side for 4 times with 4-week interval
- Primary Outcome Measures
Name Time Method The change in pigmentation level, wrinkle and texture Baseline, 4, 8, 12 weeks after the first treatment and 3, 6 months after the last treatment Using Antera®
- Secondary Outcome Measures
Name Time Method The change in elasticity Baseline, 4, 8, 12 weeks after the first treatment and 3, 6 months after the last treatment Using Cutometer®
Overall improvement by physicians and patients 4, 8, 12 weeks after the first treatment and 3, 6 months after the last treatment 5-point GAIS
Adverse events 4, 8, 12 weeks after the first treatment and 3, 6 months after the last treatment Side effects
Pain score Baseline, 4, 8, 12 weeks after the first treatment Visual analog scale (0-10; no pain-worst pain possible)